» Articles » PMID: 32943924

PIF1 Affects the Proliferation and Apoptosis of Cervical Cancer Cells by Influencing TERT

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2020 Sep 18
PMID 32943924
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Cervical cancer is a common malignancy in female and it is a serious disease threatening women's lives. We aimed to explore whether PIF1 helicase expression could affect cell proliferation and apoptosis, and whether its mechanisms were related to the expression and activity of TERT.

Methods: Western blot analysis was used to detect the expressions of PIF1 and TERT in End1/E6E7, Hela, SiHa, Ca-Ski and C-33A cells and apoptosis-related proteins (Bax, Bcl-2 and Caspase-3). RT-qPCR and Western blot analysis determined the expressions of PIF1 and TERT after transfection. After transfection or cycloastragenol (CAG) treatment, the proliferation, apoptosis, cell cycle and telomerase TERT activity were analyzed by CCK-8 assay, flow cytometry analysis and ELISA assay. Co-immunoprecipitation assay was used to verify the interactions between PIF1 and TERT.

Results: The expressions of PIF1 and TERT in End1/E6E7, Hela, SiHa, Ca-Ski and C-33A cells were increased. As PIF1 and TERT expressions in C-33A cells showed the minimum increase, C-33A cells were chosen for the next study. PIF1 interference inhibited the proliferation, decreased the ratio of G2/M phase and promoted apoptosis of transfected cells, and PIF1 interference promoted the expressions of Bax and Caspase-3 and suppressed the Bcl-2 expression. Furthermore, PIF1 interference down-regulated the telomerase activity. The effect of PIF1 overexpression was opposite to that of PIF1 interference. Co-immunoprecipitation assay demonstrated that PIF1 could combine with TERT. CAG treatment effectively reversed the effect of PIF1 interference on proliferation, cycle and apoptosis of C-33A cells transfected with shRNA-PIF1. Moreover, CAG treatment increased the expressions of PIF1 and TERT.

Discussion: PIF1 helicase could promote the proliferation and suppress the apoptosis of cervical cancer cells by down-regulating the activity of telomerase TERT.

Citing Articles

Machine learning-derived prognostic signature integrating programmed cell death and mitochondrial function in renal clear cell carcinoma: identification of PIF1 as a novel target.

Cheng G, Zhou Z, Li S, Peng F, Yang S, Ren C Cancer Immunol Immunother. 2025; 74(4):113.

PMID: 39998680 PMC: 11861773. DOI: 10.1007/s00262-025-03967-8.


Identification of PIF1 as a Ferroptosis-Related Prognostic Biomarker Correlated with Immune Infiltration in Hepatocellular Carcinoma.

Liu F, Yin P, Lu L, Yao J, Jiao B Appl Biochem Biotechnol. 2025; .

PMID: 39888492 DOI: 10.1007/s12010-024-05161-5.


Telomerase in cancer- ongoing quest and future discoveries.

Mishra A, Patel T Mol Biol Rep. 2025; 52(1):161.

PMID: 39862360 DOI: 10.1007/s11033-025-10251-6.


Structure-based discovery of first inhibitors targeting the helicase activity of human PIF1.

Wever M, Scommegna F, Egea-Rodriguez S, Dehghani-Tafti S, Brandao-Neto J, Poisson J Nucleic Acids Res. 2024; 52(20):12616-12632.

PMID: 39417423 PMC: 11551755. DOI: 10.1093/nar/gkae897.


Identification of a prognosis-related gene signature and ceRNA regulatory networks in lung adenocarcinoma.

Wei H, Teng F, Wang X, Hou X, Wang H, Wang H Heliyon. 2024; 10(7):e28084.

PMID: 38601687 PMC: 11004716. DOI: 10.1016/j.heliyon.2024.e28084.


References
1.
Geronimo C, Zakian V . Getting it done at the ends: Pif1 family DNA helicases and telomeres. DNA Repair (Amst). 2016; 44:151-158. PMC: 5441554. DOI: 10.1016/j.dnarep.2016.05.021. View

2.
Boule J, Vega L, Zakian V . The yeast Pif1p helicase removes telomerase from telomeric DNA. Nature. 2005; 438(7064):57-61. DOI: 10.1038/nature04091. View

3.
Zhao Q, Zhai Y, Liu H, Shi Y, Li X . MicroRNA-491-5p suppresses cervical cancer cell growth by targeting hTERT. Oncol Rep. 2015; 34(2):979-86. DOI: 10.3892/or.2015.4013. View

4.
Lahaye A, Leterme S, Foury F . PIF1 DNA helicase from Saccharomyces cerevisiae. Biochemical characterization of the enzyme. J Biol Chem. 1993; 268(35):26155-61. View

5.
Kirkpatrick K, Mokbel K . The significance of human telomerase reverse transcriptase (hTERT) in cancer. Eur J Surg Oncol. 2001; 27(8):754-60. DOI: 10.1053/ejso.2001.1151. View